{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:59:08Z","timestamp":1768967948390,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.7759\/cureus.25567","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T13:22:54Z","timestamp":1654089774000},"source":"Crossref","is-referenced-by-count":4,"title":["National Yearly Trend of Utilization and Procedural Complication of the Watchman Device in the United States"],"prefix":"10.7759","author":[{"given":"Biraj","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bidhya","family":"Poudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DilliRam","family":"Poudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Diaz Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: The KP-RHYTHM Study","volume":"3","author":"Go AS","year":"2018","unstructured":"Go AS, Reynolds K, Yang J, et al.. Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: The KP-RHYTHM Study. JAMA Cardiol. 2018, 3:601-8. 10.1001\/jamacardio.2018.1176","journal-title":"JAMA Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy VY","year":"2014","unstructured":"Reddy VY, Sievert H, Halperin J, et al.. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014, 312:1988-98. 10.1001\/jama.2014.15192","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v11.i2.57","article-title":"Percutaneous devices for left atrial appendage occlusion: a contemporary review","volume":"11","author":"Moussa Pacha H","year":"2019","unstructured":"Moussa Pacha H, Al-Khadra Y, Soud M, Darmoch F, Moussa Pacha A, Alraies MC. Percutaneous devices for left atrial appendage occlusion: a contemporary review. World J Cardiol. 2019, 11:57-70. 10.4330\/wjc.v11.i2.57","journal-title":"World J Cardiol"},{"key":"ref4","unstructured":"Watchman left atrial appendage closure device patient information guide. (2014). Accessed. 2021: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf13\/p130013c.pdf."},{"key":"ref5","unstructured":"Abbott\u2019s Amplatzertm Amulettm device approved by FDA to treat people with atrial fibrillation at risk of stroke. (2021). Accessed. 2021: https:\/\/abbott.mediaroom.com\/2021-08-16-Abbotts-Amplatzer-TM-Amulet-TM-Device-Approved-by-FDA-to-Treat-People-With-At...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy VY","year":"2011","unstructured":"Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011, 123:417-24. 10.1161\/CIRCULATIONAHA.110.976449","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy VY","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, et al.. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017, 70:2964-75. 10.1016\/j.jacc.2017.10.021","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma LV","year":"2017","unstructured":"Boersma LV, Ince H, Kische S, et al.. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial. Heart Rhythm. 2017, 14:1302-8. 10.1016\/j.hrthm.2017.05.038","journal-title":"Heart Rhythm"},{"key":"ref9","unstructured":"Healthcare Cost and Utilization Project (HCUP) databases. (2019). Accessed. 2021: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref10","unstructured":"Methods applying AHRQ quality indicators to Healthcare Cost and Utilization Project (HCUP) data for the 2019 National Healthcare Quality and Disparities Report (QDR). (2019). Accessed. 2021: https:\/\/www.hcup-us.ahrq.gov\/reports\/methods\/methods.jsp."},{"key":"ref11","unstructured":"International Statistical Classification of Diseases and Related Health Problems. (2019). Accessed. 2022: https:\/\/icd.who.int\/browse10\/2019\/en."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.114.001413","article-title":"Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume","volume":"8","author":"Badheka AO","year":"2015","unstructured":"Badheka AO, Chothani A, Mehta K, et al.. Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume. Circ Arrhythm Electrophysiol. 2015, 8:42-8. 10.1161\/CIRCEP.114.001413","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euaa219","article-title":"Utilization and procedural adverse outcomes associated with Watchman device implantation","volume":"23","author":"Khalil F","year":"2021","unstructured":"Khalil F, Arora S, Killu AM, et al.. Utilization and procedural adverse outcomes associated with Watchman device implantation. Europace. 2021, 23:247-53. 10.1093\/europace\/euaa219","journal-title":"Europace"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX Trial","volume":"143","author":"Kar S","year":"2021","unstructured":"Kar S, Doshi SK, Sadhu A, et al.. Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX Trial. Circulation. 2021, 143:1754-62. 10.1161\/CIRCULATIONAHA.120.050117","journal-title":"Circulation"},{"key":"ref15","unstructured":"Number of people per active physician by specialty, 2015-201. (2019). Accessed. 2022: https:\/\/www.aamc.org\/data-reports\/workforce\/interactive-data\/number-people-active-physician-specialty-2015."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99736-national-yearly-trend-of-utilization-and-procedural-complication-of-the-watchman-device-in-the-united-states","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:45Z","timestamp":1707507405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99736-national-yearly-trend-of-utilization-and-procedural-complication-of-the-watchman-device-in-the-united-states"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.25567","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}